🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Open call for abstract submission and applications for the GfMVB Emerging Scientist award and the Aletta Jacobs Award session at pcvb2025.de in Frankfurt, April 3-5, 2025! #vascularbiology #cardiovascular #EVBO #GfMVB

❤️Our January issue is out❤️ Learn about the role of piRNAs in cardiac regeneration, the paraxial mesoderm origin of lymphatic endothelium progenitors, the association between genetically predicted social activities and #Cardiovascular disease, and more! nature.com/natcardiovascr…

Although it's only January, slots are filling up quickly for #GRC_Angiogenesis! If you love vessels and wanna dig into their interactions with their neighbors, this is the place to be this summer! We will soon start selecting abstracts for short talks! Don't wait, apply today👇!

Gradually leaving Dark X. Thanks to #OpenPortability I've registered 2551 new passengers for a journey to #BlueSky. See you on the other side !

#EVBOSummerSchool 2025: spread the news! 10-11 June 2025 | Biomedicum Helsinki, Finland Registration will open soon. Stay tuned! Preceded by the excellent and free-of-charge Wihuri Research Symposium on Cardiovascular Biology! More info buff.ly/42I9fvY

This conversation below with ChatGPT made my day. And using reasoning and words NOT used in our paper. But it did not update its database to the more recent iSure-HadCre released by us in 2024...I am training it. chatgpt.com/share/67a8fe49…

5⃣ The study reveals that the most adapted immune cells reside in frontline tissues, like the lungs, which serve as gateways for respiratory pathogens Led by CNAG's Single Cell Genomics Group Leader Holger Heyn, with researchers Irepan Salvador-Martínez & Juan C. Nieto #research #singlecell

🔔 Last day for registration! #CVBE2025 Join us at 9th Annual Cardiovascular Bioengineering Symposium, organized by CNIC and NIH! #CNICConferece 🚀 📅 April 24-26, 2025 📍 Madrid, #CNIC Auditorium 📝 Free registration link in comments. Organizers 👥 jianyi zhang and

Great story on how Pik3ca GOF mutations (frequent in human vascular malformations) changes single EC behaviour 👇

The 🧵 twittorial for our new paper in Cell Stem Cell by Indranil Singh is amazing!!!!

What a title...and abstract ! The craft of writing.

I am saying goodbye as an active member of X (but find me in sandra rodriguez.bsky.social) with our exciting new paper nature. The fruit of massive work by Tommaso Vicanolo, Alaz and Jackson Li, and our superb collaborators Lai Guan NG and stefan uderhardt 🔬🧫💉📷. True teamwork! nature.com/articles/s4158…

Why humans have puzzle-shaped cells

The tool below completely changed how we do CreERT2 genetics in mice....and saves us a lot of time and number of animals needed to take solid conclusions about a gene function. Also essential for accurate scRNAseq analysis of mutant cells.

🌟 New hope for #PHTS patients! 🔬 GrauperaLab and Sandra Castillo finds at Cancer Discovery that common anticancer drugs targeting PI3K downstream effectors reduce vascular malformations & pain in a novel PHTS mouse model Read the full story! 🔗 carrerasresearch.org/en/news/common…

Excellent Postdoctoral or Experienced/Junior Researcher Funding schemes for scientists moving to Germany : humboldt-foundation.de/en/apply/spons… humboldt-foundation.de/en/apply/spons…

It seems the FDA wants the replacement of animal testing with human-related in vitro models. This means the end of physiologically relevant pre-clinical research in the US. It also implies that the first animal to be tested on a new drug will be... humans. fda.gov/news-events/pr…

Another beautiful work from the Yaniv Lab-Weizmann Institute at Weizmann Institute led by super talented student Giuseppina Lambiase and co-supervised by Rudra Nayan Das and me! So proud of Pina, who worked so hard under the very tough circumstances in Israel, to bring this paper to life! 🌟 Read it 👇!

Absolutely thrilled to share with you the final version of EPIclone, out now (open access) in nature. This has been an amazing collaboration with the lab of Lars Velten (@larsplus) at Centre for Genomic Regulation (CRG) nature.com/articles/s4158…

A must watch